Latest filing published 05 Aug 2026 for Arcutis Biotherapeutics, Inc., €99k.
This profile gathers the share dealings of Todd Watanabe in Arcutis Biotherapeutics, Inc. We count 9 filings; the first trade dates from 4 August 2025 and the latest from 3 August 2026.
On the market, this insider has only sold: 8 sales, €2.2M in total. Besides market trades, the filings include 1 share grant. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 5 August 2026, reports an open-market sale of €99k in Arcutis Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations